Introduction

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

Introduction Publisher

Aghamir SMK¹

Show Affiliations

1. Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Liquid Biopsy in Urogenital Cancers and its Clinical Utility Published:2022

Abstract

Cancer is a critical public health issue globally and is known to be the second most common cause of death in North America [1]. Over all, it is estimated that about 600, 000 deaths occurred in the United States in 2020 due to cancers, and 1, 800, 000 Americans were diagnosed as new cancer cases in 2020 alone [1, 2]. © 2022 Elsevier Inc. All rights reserved.

Related Docs

View other Related Docs

1. Overview of Liquid Biopsy, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)

2. Liquid Biopsy As a New Tool for Diagnosis, Monitoring, and Personalized Medicine in Urogenital Cancers, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)

3. Circulating Tumor Cells and Dnas in Prostate Tumors, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)

4. Liquid Biopsy in Female Genital Tract (Ovarian Cancer, Endometrial Tumor, and Cervical Tumor), Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)

5. Liquid Biopsy in Bladder Tumors, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)

6. Liquid Biopsy in Pediatric Urogenital Tumors, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)

7. Age Limit for Familial Prostate Cancer Screening, Caspian Journal of Internal Medicine (2025)

8. The Gene Manipulation and Cellular Immunotherapy Combination in the Treatment of Cancer, Iranian Journal of Biotechnology (2022)

Experts (# of related papers)

View all Related Experts

Seyed Mohammad Kazem Aghamir Mohammad Ali (11)

Seyed Mohammad Ghahestani (1)

Other Related Docs

9. Liquid Biopsy in Male Genital Tract: Testis Tumor, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)

10. The Role of Methylation Quantification of Circulating Tumor Dna (Ctdna) As a Diagnostic Biomarker of Pheochromocytomas (Pccs) and Paragangliomas (Pgls), Journal of Diabetes and Metabolic Disorders (2024)

11. The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade, Clinical Genitourinary Cancer (2023)

12. Liquid Biopsy in Kidney Tumor, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)

13. The Effect of Mesenchymal Stem Cells-Derived Exosomes on the Prostate, Bladder, and Renal Cancer Cell Lines, Scientific Reports (2022)

14. Diagnostic Accuracy of Predictive Models in Prostate Cancer: A Systematic Review and Meta-Analysis, Prostate Cancer (2022)

Style	Citing Format
MLA	Aghamir SMK. "Introduction." Liquid Biopsy in Urogenital Cancers and its Clinical Utility, vol. , no. , 2022, pp. 1-4.
APA	Aghamir SMK (2022). Introduction. Liquid Biopsy in Urogenital Cancers and its Clinical Utility, (), 1-4.
Chicago	Aghamir SMK. "Introduction." Liquid Biopsy in Urogenital Cancers and its Clinical Utility , no. (2022): 1-4.
Harvard	Aghamir SMK (2022) 'Introduction', Liquid Biopsy in Urogenital Cancers and its Clinical Utility, (), pp. 1-4.
Vancouver	Aghamir SMK. Introduction. Liquid Biopsy in Urogenital Cancers and its Clinical Utility. 2022;():1-4.
BibTex	@article{ author = {Aghamir SMK}, title = {Introduction}, journal = {Liquid Biopsy in Urogenital Cancers and its Clinical Utility}, volume = {}, number = {}, pages = {1-4}, year = {2022} }
RIS	TY - JOUR AU - Aghamir SMK TI - Introduction JO - Liquid Biopsy in Urogenital Cancers and its Clinical Utility VL - IS - SP - 1 EP - 4 PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract